YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Sanofi India

Sanofi India

BSE: 500674|NSE: SANOFI|ISIN: INE058A01010|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Mar 04, 16:00
8326.90
33.1 (0.4%)
VOLUME 4,480
LIVE
NSE
Mar 04, 15:57
8319.05
27.4 (0.33%)
VOLUME 12,286
News on Sanofi India
Select Year: 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Hold Aventis Pharma, target of Rs 1278: Broker

4.30 pm | 28 Oct 2005

Broking house, ASK Raymond James is confident about Aventis Pharma. It has maintained a 'hold rating' on the company with a target price of Rs 1278....

Aventis Pharma an outperformer, says broker

5.33 pm | 26 Oct 2005

Broking house, Prabhudas Lilladher is bullish on Aventis Pharma. It has reiterated an 'outperformer' rating on the company. ...

Aventis Pharma Q3 net profit up at Rs 49.7cr

10.23 am | 26 Oct 2005

Aventis Pharma has announced its third quarter results. The company's Q3 net profit is up at Rs 49.7 crore from Rs 42.5 crore....

Brokers bullish on Aventis Pharma

5.28 pm | 12 Aug 2005

Broking houses are bullish on Aventis Pharma. CLSA has recommended a 'Buy rating' on the company. ...

Aventis Pharma Q2 net up at Rs 34.2cr

7.45 pm | 01 Aug 2005

Aventis Pharma has announced its second quarter results. The company's Q2 net profit is up at Rs 34.2 crore as against Rs 33.4 crore. ...

Aventis Pharma Q1 net down 26% at Rs 23.6 cr

9.28 am | 29 Apr 2005

Aventis Pharma has posted 26.25% decline in Q1 net profit at Rs 23.60 crore YoY, while net sales are at Rs 174.10 crore....

1
Quick Links for Sanofi India
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.